Fig. 2From: DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3Appearance of tumors with both invasive and in situ components. The majority of DCIS was located on the periphery of the invasive tumor (<2 mm from invasion) or intermixed with it, not distant from the invasive tumorBack to article page